Results 211 to 220 of about 21,302 (228)

Role of DOAC plasma concentration on perioperative blood loss and transfusion requirements in patients with hip fractures

European Journal of Trauma and Emergency Surgery, 2022
H. Hofer, D. Oberladstätter, C. Schlimp, W. Voelckel, Johannes Zipperle, C. Lockie, O. Grottke, M. Osuchowski, H. Schöchl   +8 more
semanticscholar   +1 more source

Patients with higher body mass index treated with direct / novel oral anticoagulants (DOAC / NOAC) for atrial fibrillation experience worse clinical outcomes.

International Journal of Cardiology, 2019
INTRODUCTION Due to fixed dosing of direct oral anticoagulants (DOACs), uncertainty exists about their efficacy in a population of obese/overweight patients.
Marko Lucijanić, Ivana Jurin, H. Jurin, T. Lucijanić, B. Starčević, M. Skelin, A. Glasnović, J. Ćatić, Andjela Jurišić, I. Hadžibegović   +9 more
semanticscholar   +1 more source

DOACs in morbid obesity

Evidence-Based Practice, 2021
Krista Cowan, Steven Fox, Michael Shepherd   +2 more
openaire   +1 more source

Interference of DOAC stop and DOAC remove in the thrombin generation assay and coagulation assays

Thrombosis Research, 2020
Tinne Monteyne, Pieter De Kesel, Katrien M.J. Devreese   +2 more
openaire   +2 more sources

DOACs in Cat

Archives of Community and Family Medicine, 2018
Guneet Sarai, Nutan Fnu
openaire   +1 more source

Reply: DOACs for AF After TAVR: Are DOACs Really on First Base?

JACC. Cardiovascular interventions, 2021
Kawashima, Hideyuki, Watanabe, Yusuke, Hioki, Hirofumi, Kozuma, Ken, Yamamoto, Masanori, Hayashida, Kentaro   +5 more
openaire   +2 more sources

DOACs for AF After TAVR: Are DOACs Really on First Base?

JACC. Cardiovascular interventions, 2021
Abhishek C, Sawant, Michael, Megaly, Ashish, Pershad   +2 more
openaire   +1 more source

Critical bleeding-associated to DOACs administration

Medicina Intensiva (English Edition), 2023
Manuel, Quintana, José A, Páramo
openaire   +2 more sources

Performance Characteristics of DOAC-Remove for Neutralization of the Effects of Apixaban and Rivaroxaban in Lupus Anticoagulant Assays.

American Journal of Clinical Pathology, 2021
John M. Skaugen, Christine Sayre, A. Hassett, I. Chibisov, F. Bontempo, M. Meyer, J. Seheult   +6 more
semanticscholar   +1 more source

Paxlovid for a Patient on a DOAC

2022
openaire   +1 more source